Sage Therapeutics, Inc
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SAGE Company Description
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
SAGE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SAGE Smart Score
Score Breakdown
SAGE Company Description
Show More
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SAGE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SAGE's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of SAGE in WallStreetBets Daily Discussion
SAGE News
Recent insights relating to SAGE
CNBC Recommendations
Recent picks made for SAGE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SAGE
Corporate Flights
Flights by private jets registered to SAGE
Our Analysis